What was claimed
An internal AMA email was sent to 847,000 doctors directing them not to recommend PEMF/frequency therapies or risk losing their license, despite acknowledging it works for tissue regeneration, pain, immune modulation, and even cancer — all to protect pharmaceutical revenue. Doctors know frequency heals but stay silent.
Our verdict
Needs CautionThis asserts a specific covert motive for a purported AMA directive without any supporting evidence and attributes regulatory and practice patterns to protecting pharmaceutical revenue. Decisions about therapies typically hinge on evidence, regulation, and safety, and there is no documented AMA policy or email stating this motive. This is a sweeping generalization implying near-universal secret knowledge and deliberate silence among doctors, which is not supported by evidence. Some clinicians use or study PEMF and related modalities for specific indications, but many remain skeptical or cautious due to mixed or limited evidence, and their positions are openly discussed in the literature and policy documents.
Check your own claim
Paste any statement, headline, or AI answer — 3 independent AIs verify it in seconds, with sources.
Key findings
The directive was issued "all to protect pharmaceutical revenue."
Doctors know frequency heals but stay silent.
The directive (if true) was motivated by protecting pharmaceutical revenue.
An internal AMA email was sent to 847,000 doctors directing them not to recommend PEMF/frequency therapies or risk losing their license.
The email acknowledged PEMF/frequency therapies work for tissue regeneration, pain, immune modulation, and even cancer.